ENTITY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (1349 HK)

139
Analysis
Health Care • China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is primarily engaged in the innovative research and development, production, and marketing of biopharmaceuticals. The company offers a range of products including photodynamic technology drugs like aminolevulinic acid hydrochloride and hemoporfin, doxorubicin liposome under the Libord brand, genetic engineering drugs, and oral solid preparation technology drugs. It is headquartered in Zhangjiang Hi-Tech Park, Pudong, Shanghai, China, and was established in November 1996.
more
•14 Jun 2026 10:15

A-H Premium Weekly (Jun 12th): Remegen, ZTE, Chalco, Shandong Gold Mining Co Lt-H

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Remegen, ZTE, Chalco, Shandong Gold Mining Co Lt-H.

Logo
101 Views
Share
•07 Jun 2026 10:00

A-H Premium Weekly (Jun 5th): Yankuang Energy, Haier Smarthome, Times Electric, China Coal, Ping An

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Yankuang Energy, Haier Smarthome, Times Electric, China...

Logo
138 Views
Share
•31 May 2026 10:15

A-H Premium Weekly (May 29th): Zhuzhou Crrc Times Electric, ZTE, China Minsheng Banking

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Zhuzhou Crrc Times Electric, ZTE, China Minsheng Banking,...

Logo
128 Views
Share
•24 May 2026 10:15

A-H Premium Weekly (May 22nd): China Longyuan Power, Eastroc, CIMC, Remegen

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Longyuan Power, Eastroc, CIMC, Remegen.

Logo
91 Views
Share
•17 May 2026 10:15

A-H Premium Weekly (May 15th): Datang Power, CIMC, Beone Medicines, Midea, Weichai Power

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Datang Power, CIMC, Beone Medicines, Midea, Weichai Power,...

Logo
101 Views
Share
x